Center for Pediatric Heart Valve Disorders News & Announcements

On May 6, 7, and 8, scientists, staff, and students from CHOP and the University of Pennsylvania community celebrated the next generation of pediatric researchers and the continuation of collaborative scientific discovery at the Poster Day and Scientific Symposium.

CHOP researchers test novel system to help patients with severe complication related to congenital heart disease avoid open heart surgery.

A multimillion-dollar gift from the Topolewski’s will further advance both clinical and basic science research at CHOP to treat pediatric heart valve disease.

Learn about the home renovations funded by CAPP+ to reduce asthma triggers and more in this week’s edition of In the News.

In this news roundup, learn about the achievements of CHOP researchers from societal inductions to grant- and grand-prize recipients.

Researchers explore how serotonin may affect the heart’s mitral valve and potentially accelerate degenerative mitral regurgitation.

Structural degeneration of bioprosthetic heart valves can be prevented, according to new study from the Center for Pediatric Heart Valve Disorders.

This week’s research news features Kathrin Bernt, MD, and Richard Aplenc, MD, PhD, MSCE, recipients of Children’s Cancer Research Fund Awards.

CHOP was the lead enrolling site in the clinical trial that led to the approval of the Harmony™ Transcatheter Pulmonary Valve (TPV).

Multidisciplinary team takes a coordinated approach to treat valve diseases and expand the existing knowledge of these complex conditions.